Male carriers of HLA-C*04:01 have increased risk of cardiac injury in COVID-19

Phillip Suwalski , Michele Violano , Melina Müller‎ , Dimitri Patriki , Charlotte Thibeault , Claudia Quedenau , Xiaomin Wang , Zehra Karadeniz‎ , Jacopo Saccomanno , Jan-Moritz Doehn , Ralf-Harto‎ Hübner , Bernd Hinzmann , H. Juerg Beer , Benedikt Wiggli , Sandra Siemann , Norbert Suttorp , Martin Witzenrath , Stefan Hippenstiel , Carsten Skurk‎ , Wolfgang Poller , Pa-COVID Study Group , Leif E. Sander , Florian Kurth‎ , Tatiana Borodina , Toumy Guettouche , Ulf Landmesser , Bettina Heidecker

The Journal of Cardiovascular Aging ›› 2022, Vol. 2 ›› Issue (3) : 33

PDF
The Journal of Cardiovascular Aging ›› 2022, Vol. 2 ›› Issue (3) :33 DOI: 10.20517/jca.2022.19
Brief Report

Male carriers of HLA-C*04:01 have increased risk of cardiac injury in COVID-19

Author information +
History +
PDF

Abstract

Identification of factors that lead to the severe clinical course of COVID-19 is crucial for timely allocation of resources. The purpose of this study was to evaluate possible sex differences in cardiac injury associated with HLA-C*04:01. High sensitivity troponin T on admission (hs-TnTa) and maximum high sensitivity troponin T (hs-TnTmax) were used to assess for cardiac injury in patients with COVID-19 (n = 435). We tested for the association of elevated hs-TnT with HLA-C* 04:01 and evaluated for potential sex-specific differences. An association between hs-TnTa and the severity of clinical course was identified. In addition, our study revealed that hs-TnTmax was higher in men who were carriers of HLA-C*04:01 compared to men without the risk allele. Male carriers of HLA-C*04:01 with COVID-19 developed higher hs-TnTmax, suggesting a larger extent of cardiac injury. This association suggests the presence of different pathomechanisms in COVID-19 based on sex.

Keywords

Genetic, HLA, HLA-C / HLA-C*04:01, COVID-19, troponin T, hs-TnT

Cite this article

Download citation ▾
Phillip Suwalski, Michele Violano, Melina Müller‎, Dimitri Patriki, Charlotte Thibeault, Claudia Quedenau, Xiaomin Wang, Zehra Karadeniz‎, Jacopo Saccomanno, Jan-Moritz Doehn, Ralf-Harto‎ Hübner, Bernd Hinzmann, H. Juerg Beer, Benedikt Wiggli, Sandra Siemann, Norbert Suttorp, Martin Witzenrath, Stefan Hippenstiel, Carsten Skurk‎, Wolfgang Poller, Pa-COVID Study Group, Leif E. Sander, Florian Kurth‎, Tatiana Borodina, Toumy Guettouche, Ulf Landmesser, Bettina Heidecker. Male carriers of HLA-C*04:01 have increased risk of cardiac injury in COVID-19. The Journal of Cardiovascular Aging, 2022, 2(3): 33 DOI:10.20517/jca.2022.19

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Weiner J,Holtgrewe M.Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01.EClinicalMedicine2021;40:101099 PMCID:PMC8410317

[2]

Wang D,Hu C.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China.JAMA2020;323:1061-9 PMCID:PMC7042881

[3]

Huang C,Li X.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet2020;395:497-506 PMCID:PMC7159299

[4]

Ruan Q,Wang W,Song J.Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.Intensive Care Med2020;46:846-8

[5]

Lu R,Li J.Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.Lancet2020;395:565-74 PMCID:PMC7159086

[6]

Collet JP,Barbato E.2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.Eur Heart J2021;42:1289-367

[7]

Lala A,Russak AJ.Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection.medRxiv2020;

[8]

Lorente-Ros A,Rincón LM.Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients.Cardiol J2020;27:489-96 PMCID:PMC8078990

[9]

Sandoval Y,Jaffe AS.Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week.J Am Coll Cardiol2020;76:1244-58 PMCID:PMC7833921

[10]

Romiti GF,Toriello F.Sex-specific cut-offs for high-sensitivity cardiac troponin: is less more?.Cardiovasc Ther2019;2019:9546931 PMCID:PMC6739766

[11]

García de Guadiana-Romualdo L,Rodríguez-Fraga O.Cardiac troponin and COVID-19 severity: results from BIOCOVID study.Eur J Clin Invest2021;51:e13532 PMCID:PMC7995181

[12]

Hoffmann M,Schroeder S.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.Cell2020;181:271-280.e8 PMCID:PMC7102627

[13]

Nägele MP,Tanner FC,Flammer AJ.Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.Atherosclerosis2020;314:58-62 PMCID:PMC7554490

[14]

Gebhard C,Neuhauser HK,Klein SL.Impact of sex and gender on COVID-19 outcomes in Europe.Biol Sex Differ2020;11:29 PMCID:PMC7247289

[15]

Lombardi CM,Iorio A.Association of troponin levels with mortality in italian patients hospitalized with coronavirus disease 2019: results of a multicenter study.JAMA Cardiol2020;5:1274-80 PMCID:PMC7450398

[16]

Pauklin S,Bachmann G,Petersen-Mahrt SK.Estrogen directly activates AID transcription and function.J Exp Med2009;206:99-111 PMCID:PMC2626679

[17]

Bouman A,Faas MM.Sex hormones and the immune response in humans.Hum Reprod Update2005;11:411-23

[18]

Ding T,Wang T.A multi-hospital study in Wuhan, China: protective effects of non-menopause and female hormones on SARS-CoV-2 infection.medRxiv2020;

[19]

Dietl A,Brandl C.Distribution and specificity of high-sensitivity cardiac troponin T in older adults without acute cardiac conditions: cross-sectional results from the population-based AugUR study.BMJ Open2021;11:e052004 PMCID:PMC8565570

[20]

Subramanya V,Ouyang P.Sex hormone levels and change in left ventricular structure among men and post-menopausal women: the multi-ethnic study of atherosclerosis (MESA).Maturitas2018;108:37-44 PMCID:PMC5752123

[21]

Banerjee D,Banerjee A.Troponins, acute coronary syndrome and renal disease: from acute kidney injury through end-stage kidney disease.Eur Cardiol2019;14:187-90 PMCID:PMC6950405

AI Summary AI Mindmap
PDF

46

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/